Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Dopamine synthesis capacity correlates with µ-opioid receptor availability in the human basal ganglia: A triple-tracer PET study.

Majuri J, Joutsa J, Arponen E, Forsback S, Kaasinen V.

Neuroimage. 2018 Dec;183:1-6. doi: 10.1016/j.neuroimage.2018.07.069. Epub 2018 Aug 2.

PMID:
30077742
2.

Aerobic exercise modulates anticipatory reward processing via the μ-opioid receptor system.

Saanijoki T, Nummenmaa L, Tuulari JJ, Tuominen L, Arponen E, Kalliokoski KK, Hirvonen J.

Hum Brain Mapp. 2018 Oct;39(10):3972-3983. doi: 10.1002/hbm.24224. Epub 2018 Jun 8.

PMID:
29885086
3.

Serotonin transporter density in binge eating disorder and pathological gambling: A PET study with [11C]MADAM.

Majuri J, Joutsa J, Johansson J, Voon V, Parkkola R, Alho H, Arponen E, Kaasinen V.

Eur Neuropsychopharmacol. 2017 Dec;27(12):1281-1288. doi: 10.1016/j.euroneuro.2017.09.007. Epub 2017 Oct 9.

PMID:
29032922
4.

Opioid Release after High-Intensity Interval Training in Healthy Human Subjects.

Saanijoki T, Tuominen L, Tuulari JJ, Nummenmaa L, Arponen E, Kalliokoski K, Hirvonen J.

Neuropsychopharmacology. 2018 Jan;43(2):246-254. doi: 10.1038/npp.2017.148. Epub 2017 Jul 19.

5.

Social Laughter Triggers Endogenous Opioid Release in Humans.

Manninen S, Tuominen L, Dunbar RI, Karjalainen T, Hirvonen J, Arponen E, Hari R, Jääskeläinen IP, Sams M, Nummenmaa L.

J Neurosci. 2017 Jun 21;37(25):6125-6131. doi: 10.1523/JNEUROSCI.0688-16.2017. Epub 2017 May 23.

6.

Brain Cholinergic Function and Response to Rivastigmine in Patients With Chronic Sequels of Traumatic Brain Injury: A PET Study.

Östberg A, Virta J, Rinne JO, Oikonen V, Luoto P, Någren K, Arponen E, Tenovuo O.

J Head Trauma Rehabil. 2018 Jan/Feb;33(1):25-32. doi: 10.1097/HTR.0000000000000279.

PMID:
28060207
7.

Dopamine and Opioid Neurotransmission in Behavioral Addictions: A Comparative PET Study in Pathological Gambling and Binge Eating.

Majuri J, Joutsa J, Johansson J, Voon V, Alakurtti K, Parkkola R, Lahti T, Alho H, Hirvonen J, Arponen E, Forsback S, Kaasinen V.

Neuropsychopharmacology. 2017 Apr;42(5):1169-1177. doi: 10.1038/npp.2016.265. Epub 2016 Nov 24.

8.

Increased striatal VMAT2 binding in mice after chronic administration of methcathinone and manganese.

Asser A, Kõks S, Snellman A, Haaparanta-Solin M, Arponen E, Grönroos T, Nairismägi J, Bergquist J, Soomets U, Piip P, Eltermaa M, Sauk M, Lindmäe H, Rinne JO, Taba P.

Brain Res. 2016 Dec 1;1652:97-102. doi: 10.1016/j.brainres.2016.09.034. Epub 2016 Sep 28.

PMID:
27693414
9.

Social touch modulates endogenous μ-opioid system activity in humans.

Nummenmaa L, Tuominen L, Dunbar R, Hirvonen J, Manninen S, Arponen E, Machin A, Hari R, Jääskeläinen IP, Sams M.

Neuroimage. 2016 Sep;138:242-247. doi: 10.1016/j.neuroimage.2016.05.063. Epub 2016 May 27.

PMID:
27238727
10.

Detecting a dexmedetomidine-evoked reduction of noradrenaline release in the human brain with the alpha2C-adrenoceptor PET ligand [11C]ORM-13070.

Lehto J, Scheinin A, Johansson J, Marjamäki P, Arponen E, Scheinin H, Scheinin M.

Synapse. 2016 Feb;70(2):57-65. doi: 10.1002/syn.21872. Epub 2015 Nov 26.

PMID:
26562363
11.

Sensitivity of [(11)C]ORM-13070 to increased extracellular noradrenaline in the CNS - a PET study in human subjects.

Lehto J, Johansson J, Vuorilehto L, Luoto P, Arponen E, Scheinin H, Rouru J, Scheinin M.

Psychopharmacology (Berl). 2015 Nov;232(21-22):4169-78. doi: 10.1007/s00213-015-3941-y. Epub 2015 Apr 29.

PMID:
25918111
12.

Imaging of α2C-adrenoceptors in the living brain: a method to monitor noradrenaline release?

Scheinin M, Lehto J, Johansson J, Luoto P, Arponen E, Vuorilehto L, Scheinin H, Rouru J.

Springerplus. 2015 Jun 12;4(Suppl 1):L20. doi: 10.1186/2193-1801-4-S1-L20. eCollection 2015. No abstract available.

13.

Validation of [(11) C]ORM-13070 as a PET tracer for alpha2c -adrenoceptors in the human brain.

Lehto J, Hirvonen MM, Johansson J, Kemppainen J, Luoto P, Naukkarinen T, Oikonen V, Arponen E, Rouru J, Sallinen J, Scheinin H, Vuorilehto L, Finnema SJ, Halldin C, Rinne JO, Scheinin M.

Synapse. 2015 Mar;69(3):172-81. doi: 10.1002/syn.21798. Epub 2015 Jan 8.

PMID:
25530024
14.

Amphetamine decreases α2C-adrenoceptor binding of [11C]ORM-13070: a PET study in the primate brain.

Finnema SJ, Hughes ZA, Haaparanta-Solin M, Stepanov V, Nakao R, Varnäs K, Varrone A, Arponen E, Marjamäki P, Pohjanoksa K, Vuorilehto L, Babalola PA, Solin O, Grimwood S, Sallinen J, Farde L, Scheinin M, Halldin C.

Int J Neuropsychopharmacol. 2014 Dec 13;18(3). pii: pyu081. doi: 10.1093/ijnp/pyu081.

15.

Automated reference region extraction and population-based input function for brain [(11)C]TMSX PET image analyses.

Rissanen E, Tuisku J, Luoto P, Arponen E, Johansson J, Oikonen V, Parkkola R, Airas L, Rinne JO.

J Cereb Blood Flow Metab. 2015 Jan;35(1):157-65. doi: 10.1038/jcbfm.2014.194. Epub 2014 Nov 5.

16.

Test-retest reliability of (11)C-ORM-13070 in PET imaging of α2C-adrenoceptors in vivo in the human brain.

Lehto J, Virta JR, Oikonen V, Roivainen A, Luoto P, Arponen E, Helin S, Hietamäki J, Holopainen A, Kailajärvi M, Peltonen JM, Rouru J, Sallinen J, Virtanen K, Volanen I, Scheinin M, Rinne JO.

Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):120-7. doi: 10.1007/s00259-014-2899-z. Epub 2014 Sep 9.

PMID:
25201008
17.

DRD2-related TaqIA genotype is associated with dopamine release during a gambling task.

Joutsa J, Hirvonen MM, Arponen E, Hietala J, Kaasinen V.

J Addict Med. 2014 Jul-Aug;8(4):294-5. doi: 10.1097/ADM.0000000000000037. No abstract available.

PMID:
25089954
18.

¹¹C-ORM-13070, a novel PET ligand for brain α₂C-adrenoceptors: radiometabolism, plasma pharmacokinetics, whole-body distribution and radiation dosimetry in healthy men.

Luoto P, Suilamo S, Oikonen V, Arponen E, Helin S, Herttuainen J, Hietamäki J, Holopainen A, Kailajärvi M, Peltonen JM, Rouru J, Sallinen J, Scheinin M, Virta J, Virtanen K, Volanen I, Roivainen A, Rinne JO.

Eur J Nucl Med Mol Imaging. 2014 Oct;41(10):1947-56. doi: 10.1007/s00259-014-2782-y. Epub 2014 May 17.

PMID:
24838249
19.

A PET Tracer for Brain α2C Adrenoceptors, (11)C-ORM-13070: Radiosynthesis and Preclinical Evaluation in Rats and Knockout Mice.

Arponen E, Helin S, Marjamäki P, Grönroos T, Holm P, Löyttyniemi E, Någren K, Scheinin M, Haaparanta-Solin M, Sallinen J, Solin O.

J Nucl Med. 2014 Jul;55(7):1171-7. doi: 10.2967/jnumed.113.135574. Epub 2014 May 5.

20.

Mesolimbic dopamine release is linked to symptom severity in pathological gambling.

Joutsa J, Johansson J, Niemelä S, Ollikainen A, Hirvonen MM, Piepponen P, Arponen E, Alho H, Voon V, Rinne JO, Hietala J, Kaasinen V.

Neuroimage. 2012 May 1;60(4):1992-9. doi: 10.1016/j.neuroimage.2012.02.006. Epub 2012 Feb 14.

PMID:
22348881
21.

Improved detection of localized prostate cancer using co-registered MRI and 11C-acetate PET/CT.

Jambor I, Borra R, Kemppainen J, Lepomäki V, Parkkola R, Dean K, Alanen K, Arponen E, Nurmi M, Aronen HJ, Minn H.

Eur J Radiol. 2012 Nov;81(11):2966-72. doi: 10.1016/j.ejrad.2011.12.043. Epub 2012 Feb 18.

PMID:
22342610
22.

Cholinergic dysfunction after traumatic brain injury: preliminary findings from a PET study.

Östberg A, Virta J, Rinne JO, Oikonen V, Luoto P, Någren K, Arponen E, Tenovuo O.

Neurology. 2011 Mar 22;76(12):1046-50. doi: 10.1212/WNL.0b013e318211c1c4.

PMID:
21422456
23.

Functional imaging of localized prostate cancer aggressiveness using 11C-acetate PET/CT and 1H-MR spectroscopy.

Jambor I, Borra R, Kemppainen J, Lepomäki V, Parkkola R, Dean K, Alanen K, Arponen E, Nurmi M, Aronen HJ, Minn H.

J Nucl Med. 2010 Nov;51(11):1676-83. doi: 10.2967/jnumed.110.078667. Epub 2010 Oct 18.

24.

Assessment of islet specificity of dihydrotetrabenazine radiotracer binding in rat pancreas and human pancreas.

Fagerholm V, Mikkola KK, Ishizu T, Arponen E, Kauhanen S, Någren K, Solin O, Nuutila P, Haaparanta M.

J Nucl Med. 2010 Sep;51(9):1439-46. doi: 10.2967/jnumed.109.074492. Epub 2010 Aug 18.

25.

Visual assessment of [(11)C]PIB PET in patients with cognitive impairment.

Suotunen T, Hirvonen J, Immonen-Räihä P, Aalto S, Lisinen I, Arponen E, Teräs M, Koski K, Sulkava R, Seppänen M, Rinne JO.

Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1141-7. doi: 10.1007/s00259-010-1382-8. Epub 2010 Feb 9.

PMID:
20143064
26.

Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer.

Seppälä J, Seppänen M, Arponen E, Lindholm P, Minn H.

Radiother Oncol. 2009 Nov;93(2):234-40. doi: 10.1016/j.radonc.2009.08.010. Epub 2009 Sep 18.

PMID:
19766336
27.

Biodistribution and radiation dosimetry of the amyloid imaging agent 11C-PIB in humans.

Scheinin NM, Tolvanen TK, Wilson IA, Arponen EM, Någren KA, Rinne JO.

J Nucl Med. 2007 Jan;48(1):128-33.

Supplemental Content

Loading ...
Support Center